<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38352809</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2284-2594</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>2</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>European journal of case reports in internal medicine</Title><ISOAbbreviation>Eur J Case Rep Intern Med</ISOAbbreviation></Journal><ArticleTitle>Thyrotoxicosis Misdiagnosed as Long Covid by Telemedicine - A Cautionary Tale.</ArticleTitle><Pagination><StartPage>004206</StartPage><MedlinePgn>004206</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">004206</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12890/2024_004206</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Individuals who have had severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may develop post-coronavirus disease conditions, also known as long COVID. The symptoms of long COVID are nonspecific, and there are similarities between the symptoms of long COVID and those of Graves' disease (GD). Therefore, it is important to rule out GD in patients suspected of having long COVID. Telemedicine is widely used to avoid the risk of SARS-CoV-2 infection. However, owing to the lack of in-person examinations, diagnostic errors can occur.</AbstractText><AbstractText Label="CASE DESCRIPTION" NlmCategory="UNASSIGNED">A 27-year-old Japanese woman presented complaining of persistent fatigue, dyspnea, and low-grade fever, and after in-person examination was finally diagnosed with GD. She had been diagnosed with SARS-CoV-2 infection four months earlier and her symptoms had resolved within 5 days but then recurred. Subsequently, she had 3 telemedicine visits and had been diagnosed with long COVID.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">With telemedicine there may be delayed diagnosis of GD in patients with a recent history of SARS-CoV-2 infection. Some symptoms and abnormalities cannot be confirmed in telemedicine visits performed using a simple mobile phone. Therefore it is important to know which findings obtained in telemedicine visits with a simple mobile phone are suggestive of GD. Low-grade fever and tachycardia are often observed in patients with GD, but rarely occur in patients with long COVID.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Tachycardia and persistent low-grade fever after SARS-CoV-2 infection, which can be confirmed by telemedicine, can be clues for the diagnosis of GD. Therefore, in-person examination should be added if these symptoms are confirmed by telemedicine.</AbstractText><AbstractText Label="LEARNING POINTS" NlmCategory="CONCLUSIONS">The symptoms of Graves 'disease (GD) and long COVID may overlap.With telemedicine there may be delayed diagnosis of GD, in patients with recent history of severe acute respiratory syndrome mediated by coronavirus 2 (SARS-CoV-2) infections.In telemedicine visits, tachycardia and persistent low-grade fever could be clues for the diagnosis of GD after SARS-CoV-2 infections on telemedicine.</AbstractText><CopyrightInformation>&#xa9; EFIM 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sawamura</LastName><ForeName>Toshitaka</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Asanogawa General Hospital, Kanazawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Promotion and Medicine of the Future, Kanazawa University, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karashima</LastName><ForeName>Shigehiro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Health Promotion and Medicine of the Future, Kanazawa University, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kometani</LastName><ForeName>Mitsuhiro</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Promotion and Medicine of the Future, Kanazawa University, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohmori</LastName><ForeName>Ai</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Asanogawa General Hospital, Kanazawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoneda</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Endocrinology and Metabolism, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Promotion and Medicine of the Future, Kanazawa University, Kanazawa, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Eur J Case Rep Intern Med</MedlineTA><NlmUniqueID>101648453</NlmUniqueID><ISSNLinking>2284-2594</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Delayed diagnosis</Keyword><Keyword MajorTopicYN="N">Graves&#x2019; disease</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword></KeywordList><CoiStatement>Conflicts of Interests: The Authors declare that there are no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>14</Day><Hour>3</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38352809</ArticleId><ArticleId IdType="pmc">PMC10860905</ArticleId><ArticleId IdType="doi">10.12890/2024_004206</ArticleId><ArticleId IdType="pii">4206</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TCO, Rosmalen JGM Lifelines Corona Research Initiative. Persistence of somatic symptoms after COVID-19 in the Netherlands: An observational cohort study. Lancet. 2022;400:452&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagami T, Tsuiki M, Nakao K, Nakatani R, Kakita M, Ueda Y, et al. Specific symptoms of thyrotoxicosis in Japanese Patients: A Reevaluation of Classical Symptoms in Modern thyroid Function Tests. J Gen Fam Med. 2016;17:225&#x2013;231.</Citation></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateu-Salat M, Urgell E, Chico A. SARS-COV-2 as a trigger for autoimmune disease: report of two cases of Graves&#x2019; disease after COVID-19. J Endocrinol Invest. 2020;43:1527&#x2013;1528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7368923</ArticleId><ArticleId IdType="pubmed">32686042</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ HLH Across Speciality Collaboration. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari N, Saheb Sharif-Askari F, Ahmed SBM, Hannawi S, Hamoudi R, Hamid Q, et al. Enhanced expression of autoantigens during SARS-CoV-2 viral infection. Front Immunol. 2021;12:686462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278821</ArticleId><ArticleId IdType="pubmed">34276672</ArticleId></ArticleIdList></Reference><Reference><Citation>Go MT, George AM, Tahsin B, Fogelfeld L. Tachycardia in hyperthyroidism: Not so common. PLoS One. 2022;17:e0273724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9439220</ArticleId><ArticleId IdType="pubmed">36054093</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamizu T. Thyroid storm: A Japanese perspective. Thyroid. 2018;28:32&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770119</ArticleId><ArticleId IdType="pubmed">28899229</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>